L. De Stefano

发表

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline

S. Bugatti, C. Montecucco, F. Bobbio-Pallavicini, 2020, RMD open.

Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study

F. Meloni, C. Montecucco, A. Valentini, 2020, Frontiers in Medicine.

Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis

S. Bugatti, C. Montecucco, L. Bogliolo, 2022, Journal of clinical medicine.

Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis

R. Caporali, S. Bugatti, A. Manzo, 2022, Annals of the Rheumatic Diseases.

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target

S. Bugatti, A. Manzo, C. Montecucco, 2021, Frontiers in Immunology.

Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis

S. Bugatti, A. Manzo, C. Montecucco, 2020, Therapeutic advances in musculoskeletal disease.

Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic

S. Bugatti, A. Manzo, C. Montecucco, 2022, Annals of the Rheumatic Diseases.

Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital

R. Bruno, S. Ludovisi, E. Cereda, 2020, Clinical Nutrition.

Transient monoarthritis and psoriatic skin lesions following COVID-19

S. Bugatti, C. Montecucco, S. Rossi, 2020, Annals of the Rheumatic Diseases.

An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations

P. Migliorini, C. Selmi, L. Iaccarino, 2022, Clinical Reviews in Allergy & Immunology.

Sporadic late-onset nemaline myopathy in a patient with silicone breast implants

A. Rossi, F. Ginanneschi, E. Frati, 2020, Clinical Neurology and Neurosurgery.

Established rheumatoid arthritis. The pathogenic aspects.

S. Bugatti, A. Manzo, E. Bozzalla Cassione, 2019, Best practice & research. Clinical rheumatology.

A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019

S. Bugatti, A. Manzo, C. Montecucco, 2020, Frontiers in Immunology.

Low Doses of Etanercept Can Be Effective to Maintain Remission in Psoriatic Arthritis Patients

E. Frati, R. de Stefano, L. De Stefano, 2017, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease

A. Iagnocco, C. Montecucco, F. Atzeni, 2022, Rheumatology.

Focal EEG changes indicating critical illness associated cerebral microbleeds in a Covid-19 patient

M. Seeck, P. Mégevand, P. De Stefano, 2020, Clinical Neurophysiology Practice.

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

F. Baldanti, D. Lilleri, S. Bugatti, 2021, Annals of the Rheumatic Diseases.

A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019

E. Cereda, R. Caccialanza, L. Bogliolo, 2020, Current opinion in clinical nutrition and metabolic care.

Tumor necrosis factor-α inhibitor-related immune disorders.

S. Bugatti, L. De Stefano, E. Mauric, 2023, Autoimmunity reviews.

Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib.

S. Bugatti, C. Montecucco, F. Bobbio-Pallavicini, 2021, Rheumatology.

Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’

S. Bugatti, A. Manzo, C. Montecucco, 2021, Annals of the Rheumatic Diseases.

The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis

S. Bugatti, A. Manzo, C. Montecucco, 2021, International journal of molecular sciences.

The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis

S. Bugatti, A. Manzo, C. Montecucco, 2023, Arthritis Research & Therapy.

Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study

C. Montecucco, F. Atzeni, G. Guggino, 2021, Clinical Rheumatology.

Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis

S. Bugatti, C. Montecucco, E. Bozzalla Cassione, 2023, Internal and Emergency Medicine.

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

P. Dieudé, M. González-Gay, M. Mejía, 2022, Clinical and experimental rheumatology.

Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry

A. Iagnocco, F. Masedu, B. Ogunjimi, 2023, RMD Open.

Adult-onset Still's disease with elderly onset, results from a multicentre study.

A. Iagnocco, S. Bugatti, C. Montecucco, 2021, Clinical and experimental rheumatology.

Autoantibody-negative rheumatoid arthritis: still a challenge for the rheumatologist.

S. Bugatti, S. Gandolfo, L. De Stefano, 2023, The Lancet. Rheumatology.

Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat

S. Bugatti, A. Manzo, G. Sakellariou, 2024, Arthritis research & therapy.

Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19

S. Bugatti, A. Manzo, C. Montecucco, 2021, Annals of the Rheumatic Diseases.

Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis

R. Caporali, S. Bugatti, C. Montecucco, 2020, Annals of the Rheumatic Diseases.